Large macroprolactinoma treated with bromocriptine alone

Annals of the Academy of Medicine Singapore

Volumn 25, Issue 6, 1996, Pages 886-889

  Loh, K C ^a,b   Shlossberg, A H ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dopamine agonist; Drug therapy; Hyperprolactinaemia; Medical treatment; Pituitary tumour

Indexed keywords

BROMOCRIPTINE; PROLACTIN;

ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PROLACTIN BLOOD LEVEL; PROLACTINOMA; VISUAL ACUITY;

ADMINISTRATION, ORAL; ADULT; BROMOCRIPTINE; DOPAMINE AGONISTS; HUMANS; MALE; PITUITARY NEOPLASMS; PROLACTIN; PROLACTINOMA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0030498172     PISSN: 03044602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Franks S, Jacobs HS, Nabarro J D Studies of prolactin in pituitary disease [proceedings] J Endocrinol 1975; 67:55P.
2. Vaidya R A, Aloorkar S D, Rege N R, Maskati B T, Jahangir R P, Sheth A R, et al. Normalization of visual fields following bromocriptine treatment in hyperprolactinemic patients with visual field constriction. Fertil Steril 1978; 29:632-6.
3. Thorner M O, Martin W H, Rogol A D, Morris J L, Perryman R L, Conway B P, et al. Rapid regression of pituitary prolactinomas during bromocriptine treatment. J Clin Endocrinol Metab 1980; 51:438-45.
4. Molitch M E, Elton R L, Blackwell R E, Caldwell B, Chang R J, Jaffe R, et al. Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study. J Clin Endocrinol Metab 1985; 60:698-705
5. Montini M, Gianola D, Pagani M D, Tengattini F, Dominom P, Sileo F, et al New perspectives in medical management of hyperprolactinemia Endocrinol Exp 1990; 24.159-66
6. Scanlon M F, Peters J R, Thomas J P, Richards S H, Morton W H, Howell S, et al Management of selected patients with hyperprolactinaemia by partial hypophysectomy. BMJ 1985; 291:1547-50.
7. Tindall GT, Kovacs K, Horvath E, Thorner MO. Human prolactin-producing adenomas and bromocriptine: A histological, immunocytochemical, ultrastructural, and morphometric study J Clin Endocrinol Metab 1982, 55:1178-83.
8. Bassetti M, Spada A, Pezzo G, Giannattasio G. Bromocriptine treatment reduces the cell size in human macroprolactinomas. A morphometric study J Clin Endocrinol Metab 1984; 58.268-73.
9. Barlas O, Bayindir C, Hepgul K, Can M, Kiris T, Sencer E, et al. Bromocriptine-induced cerebrospinal fluid fistula in patients with macroprolactinomas. report of three cases and a review of the literature. Surg Neurol 1994; 41:486-9.
10. deWit W, Coelingh B H, Gerards L J. Prophylactic bromocriptine treatment during pregnancy in women with macroprolactinomas: report of 13 pregnancies. Br J Obstet Gynaecol 1984; 91 1059-69.
11. Krupp P, Monka C Bromocriptine in pregnancy safety aspects. Klin Wochenschr 1987; 65:823-7.
12. Schwarzstein D, Garcia P A, Gimenez G, Calaf J, Puig D M, Caixas A, et al. Dopaminergic resistance in a case of invasive macroprolactinoma. J Endocrinol Invest 1993; 16.443-7.
13. Barnett PS, Dawson JM, Butler J, Coskeran PB, Maccabe JJ, McGregor A M. CV 205-502, a new non-ergot dopamine agonist, reduces prolactinoma size in man. Clin Endocrinol 1990; 33:307-16.
14. Webster J, Piscitelli G, Polli A, D'Alberton A, Falsetti L, Ferrari C, et al The efficacy and tolerability of long-term cabergoline therapy in hyperprolactinaemic disorders: an open, uncontrolled, multicentre study. European Multicentre Cabergoline Study Group. Clin Endocrinol (Oxf) 1993, 39:323-9.
15. Ciccarelli E, Miola C, Grottoli S, Avataneo T, Lancranjan I, Camanni F Long term therapy of patients with macroprolactinoma using repeatable injectable bromocriptine. J Clin Endocrinol Metab 1993; 76:484-8.
16. Thorner M O, Perryman R L, Rogol A D, Conway B P, MacLeod R M, Login I S, et al. Rapid changes of prolactinoma volume after withdrawal and reinstitution of bromocriptine J Clin Endocrinol Metab 1981; 53 480-3.
17. Faria M A J, Tindall G T Transsphenoidal microsurgery for prolactin-secreting pituitary adenomas. J Neurosurg 1982, 56.33-43.
18. Randall R V, Laws E R J, Abboud C F, Ebersold M J, Kao P C, Scheithauer B W. Transsphenoidal microsurgical treatment of prolactin-producing pituitary adenomas. Results in 100 patients. Mayo Clin Proc 1983; 58:108-21.